First-Line Treatment With Subcutaneous Epcoritamab plus R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2022）
关键词
ABCL, bispecific, diffuse large B-cell lymphoma, hematologic malignancy, non-Hodgkin lymphoma, Phase I/II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要